Skip to main content

Advertisement

Table 2 Baseline demographic characteristics of the RVO patients and control subjects

From: Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion

  RVO patients (n = 80) Control (=80) p
Age (year) 60.2 ± 12.1 59 ± 12.6 0.54
Female (%) 41 (51.3) 42 (52.5) 0.87
Hypertension (%) 43 (53.8) 22 (27.5) 0.0001*
Diabetes mellitus (%) 31 (38.8) 12 (15.0) 0.001*
Hyperlipidemia (%) 37 (46.3) 24 (30.0) 0.034*
Current smoking (%) 41 (51.3) 25 (31.3) 0.01*
History for CAD (%) 23 (28.8) 17 (21.3) 0.27
BMI (kg/m 2 ) 23.4 ± 3.1 23.8 ± 3.3 0.43
  1. *p < 0.05.
  2. Data are presented as mean ± standard deviation or number (%), where appropriate.
  3. RVO, retinal vein occlusion; CAD, coronary artery disease; BMI, body mass index.